Previous Article | Next Article 
Journal of Virology, August 1999, p. 6937-6945, Vol. 73, No. 8
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Replication-Competent Rhabdoviruses with Human Immunodeficiency
Virus Type 1 Coats and Green Fluorescent Protein: Entry by a
pH-Independent Pathway
Eli
Boritz,1
Jennifer
Gerlach,1
J. Erik
Johnson,2 and
John K.
Rose1,*
Departments of Pathology and Cell
Biology1 and Department of
Genetics,2 Yale University School of
Medicine, New Haven, Connecticut 06510
Received 8 February 1999/Accepted 28 April 1999
We describe a replication-competent, recombinant vesicular
stomatitis virus (VSV) in which the gene encoding the single
transmembrane glycoprotein (G) was deleted and replaced by an
env-G hybrid gene encoding the extracellular and
transmembrane domains of a human immunodeficiency virus type 1 (HIV-1)
envelope protein fused to the cytoplasmic domain of VSV G. An
additional gene encoding a green fluorescent protein was added to
permit rapid detection of infection. This novel surrogate virus
infected and propagated on cells expressing the HIV receptor CD4 and
coreceptor CXCR4. Infection was blocked by SDF-1, the ligand for CXCR4,
by antibody to CD4 and by HIV-neutralizing antibody. This virus, unlike
VSV, entered cells by a pH-independent pathway and thus supports a pH-independent pathway of HIV entry. Additional recombinants carrying hybrid env-G genes derived from R5 or X4R5 HIV strains also
showed the coreceptor specificities of the HIV strains from which they were derived. These surrogate viruses provide a simple and rapid assay
for HIV-neutralizing antibodies as well as a rapid screen for molecules
that would interfere with any stage of HIV binding or entry. The
viruses might also be useful as HIV vaccines. Our results suggest wide
applications of other surrogate viruses based on VSV.
*
Corresponding author. Mailing address: Department of
Pathology, Yale University School of Medicine, 310 Cedar St. (BML 342), New Haven, CT 06510. Phone: (203) 785-6794. Fax: (203) 785-7467. E-mail: John.Rose{at}yale.edu.
Journal of Virology, August 1999, p. 6937-6945, Vol. 73, No. 8
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Mire, C. E., Dube, D., Delos, S. E., White, J. M., Whitt, M. A.
(2009). Glycoprotein-Dependent Acidification of Vesicular Stomatitis Virus Enhances Release of Matrix Protein. J. Virol.
83: 12139-12150
[Abstract]
[Full Text]
-
Kugel, D., Kochs, G., Obojes, K., Roth, J., Kobinger, G. P., Kobasa, D., Haller, O., Staeheli, P., von Messling, V.
(2009). Intranasal Administration of Alpha Interferon Reduces Seasonal Influenza A Virus Morbidity in Ferrets. J. Virol.
83: 3843-3851
[Abstract]
[Full Text]
-
Newby, C. M., Sabin, L., Pekosz, A.
(2007). The RNA Binding Domain of Influenza A Virus NS1 Protein Affects Secretion of Tumor Necrosis Factor Alpha, Interleukin-6, and Interferon in Primary Murine Tracheal Epithelial Cells. J. Virol.
81: 9469-9480
[Abstract]
[Full Text]
-
Publicover, J., Ramsburg, E., Rose, J. K.
(2005). A Single-Cycle Vaccine Vector Based on Vesicular Stomatitis Virus Can Induce Immune Responses Comparable to Those Generated by a Replication-Competent Vector. J. Virol.
79: 13231-13238
[Abstract]
[Full Text]
-
Liao, M., Kielian, M.
(2005). Domain III from class II fusion proteins functions as a dominant-negative inhibitor of virus membrane fusion. JCB
171: 111-120
[Abstract]
[Full Text]
-
Kitagawa, Y., Tani, H., Limn, C. K., Matsunaga, T. M., Moriishi, K., Matsuura, Y.
(2005). Ligand-Directed Gene Targeting to Mammalian Cells by Pseudotype Baculoviruses. J. Virol.
79: 3639-3652
[Abstract]
[Full Text]
-
McKenna, P. M., Aye, P. P., Dietzschold, B., Montefiori, D. C., Martin, L. N., Marx, P. A., Pomerantz, R. J., Lackner, A., Schnell, M. J.
(2004). Immunogenicity Study of Glycoprotein-Deficient Rabies Virus Expressing Simian/Human Immunodeficiency Virus SHIV89.6P Envelope in a Rhesus Macaque. J. Virol.
78: 13455-13459
[Abstract]
[Full Text]
-
Coil, D. A., Miller, A. D.
(2004). Phosphatidylserine Is Not the Cell Surface Receptor for Vesicular Stomatitis Virus. J. Virol.
78: 10920-10926
[Abstract]
[Full Text]
-
Pichlmair, A., Buse, J., Jennings, S., Haller, O., Kochs, G., Staeheli, P.
(2004). Thogoto Virus Lacking Interferon-Antagonistic Protein ML Is Strongly Attenuated in Newborn Mx1-Positive but Not Mx1-Negative Mice. J. Virol.
78: 11422-11424
[Abstract]
[Full Text]
-
Porosnicu, M., Mian, A., Barber, G. N.
(2003). The Oncolytic Effect of Recombinant Vesicular Stomatitis Virus Is Enhanced by Expression of the Fusion Cytosine Deaminase/Uracil Phosphoribosyltransferase Suicide Gene. Cancer Res.
63: 8366-8376
[Abstract]
[Full Text]
-
Okuma, K., Dalton, K. P., Buonocore, L., Ramsburg, E., Rose, J. K.
(2003). Development of a Novel Surrogate Virus for Human T-Cell Leukemia Virus Type 1: Inhibition of Infection by Osteoprotegerin. J. Virol.
77: 8562-8569
[Abstract]
[Full Text]
-
Ebert, O., Shinozaki, K., Huang, T.-G., Savontaus, M. J., Garcia-Sastre, A., Woo, S. L. C.
(2003). Oncolytic Vesicular Stomatitis Virus for Treatment of Orthotopic Hepatocellular Carcinoma in Immune-competent Rats. Cancer Res.
63: 3605-3611
[Abstract]
[Full Text]
-
Neumann, G., Whitt, M. A., Kawaoka, Y.
(2002). A decade after the generation of a negative-sense RNA virus from cloned cDNA - what have we learned?. J. Gen. Virol.
83: 2635-2662
[Abstract]
[Full Text]
-
Reuter, J. D., Vivas-Gonzalez, B. E., Gomez, D., Wilson, J. H., Brandsma, J. L., Greenstone, H. L., Rose, J. K., Roberts, A.
(2002). Intranasal Vaccination with a Recombinant Vesicular Stomatitis Virus Expressing Cottontail Rabbit Papillomavirus L1 Protein Provides Complete Protection against Papillomavirus-Induced Disease. J. Virol.
76: 8900-8909
[Abstract]
[Full Text]
-
Buonocore, L., Blight, K. J., Rice, C. M., Rose, J. K.
(2002). Characterization of Vesicular Stomatitis Virus Recombinants That Express and Incorporate High Levels of Hepatitis C Virus Glycoproteins. J. Virol.
76: 6865-6872
[Abstract]
[Full Text]
-
Quinones-Kochs, M. I., Buonocore, L., Rose, J. K.
(2002). Role of N-Linked Glycans in a Human Immunodeficiency Virus Envelope Glycoprotein: Effects on Protein Function and the Neutralizing Antibody Response. J. Virol.
76: 4199-4211
[Abstract]
[Full Text]
-
Ring, C. J. A.
(2002). Cytolytic viruses as potential anti-cancer agents. J. Gen. Virol.
83: 491-502
[Abstract]
[Full Text]
-
van den Pol, A. N., Dalton, K. P., Rose, J. K.
(2002). Relative Neurotropism of a Recombinant Rhabdovirus Expressing a Green Fluorescent Envelope Glycoprotein. J. Virol.
76: 1309-1327
[Abstract]
[Full Text]
-
Keppler, O. T., Yonemoto, W., Welte, F. J., Patton, K. S., Iacovides, D., Atchison, R. E., Ngo, T., Hirschberg, D. L., Speck, R. F., Goldsmith, M. A.
(2001). Susceptibility of Rat-Derived Cells to Replication by Human Immunodeficiency Virus Type 1. J. Virol.
75: 8063-8073
[Abstract]
[Full Text]
-
Rose, N. F., Roberts, A., Buonocore, L., Rose, J. K.
(2000). Glycoprotein Exchange Vectors Based on Vesicular Stomatitis Virus Allow Effective Boosting and Generation of Neutralizing Antibodies to a Primary Isolate of Human Immunodeficiency Virus Type 1. J. Virol.
74: 10903-10910
[Abstract]
[Full Text]